4//SEC Filing
KROIN DAVID 4
Accession 0002015536-25-000007
CIK 0001691082other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 6:09 PM ET
Size
15.1 KB
Accession
0002015536-25-000007
Insider Transaction Report
Form 4
KROIN DAVID
10% Owner
Transactions
- Conversion
Common Stock
2025-09-12+686,138→ 686,138 total - Purchase
Common Stock
2025-09-12$15.00/sh+666,666$9,999,990→ 666,666 total(indirect: By Deep Track Special Opportunities Fund, LP) - Purchase
Common Stock
2025-09-12$15.00/sh+2,000,000$30,000,000→ 2,686,138 total - Conversion
Series C Preferred Stock
2025-09-12−16,666,667→ 0 total→ Common Stock (686,138 underlying)
Transactions
- Purchase
Common Stock
2025-09-12$15.00/sh+2,000,000$30,000,000→ 2,686,138 total - Conversion
Common Stock
2025-09-12+686,138→ 686,138 total - Conversion
Series C Preferred Stock
2025-09-12−16,666,667→ 0 total→ Common Stock (686,138 underlying) - Purchase
Common Stock
2025-09-12$15.00/sh+666,666$9,999,990→ 666,666 total(indirect: By Deep Track Special Opportunities Fund, LP)
Deep Track Capital, LP
10% Owner
Transactions
- Purchase
Common Stock
2025-09-12$15.00/sh+2,000,000$30,000,000→ 2,686,138 total - Conversion
Common Stock
2025-09-12+686,138→ 686,138 total - Purchase
Common Stock
2025-09-12$15.00/sh+666,666$9,999,990→ 666,666 total(indirect: By Deep Track Special Opportunities Fund, LP) - Conversion
Series C Preferred Stock
2025-09-12−16,666,667→ 0 total→ Common Stock (686,138 underlying)
Footnotes (3)
- [F1]Each share of Series C Preferred Stock automatically converted immediately prior to the closing of the Issuer's initial public offering for no additional consideration at a conversion ratio that was dependent upon the initial price per share to the public in the Issuer's initial public offering.
- [F2]Represents securities held by Deep Track Biotechnology Master Fund, Ltd. Deep Track Capital, LP is the investment manager of Deep Track Biotechnology Master Fund, Ltd. Mr. David Kroin is the managing member of Deep Track Capital GP, LLC, the general partner of Deep Track Capital, LP., and by virtue of such status may be deemed to be the beneficial owner of the shares owned by Deep Track Biotechnology Master Fund, Ltd. Deep Track Capital, LP and Mr. Kroin disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests.
- [F3]Represents securities held by Deep Track Special Opportunities Fund, LP. Deep Track Capital, LP is the investment manager of Deep Track Special Opportunities Fund LP. Mr. David Kroin is the managing member of Deep Track Capital GP, LLC, the general partner of Deep Track Capital, LP., and by virtue of such status may be deemed to be the beneficial owner of the shares owned by Deep Track Special Opportunities Fund, LP. Deep Track Capital, LP and Mr. Kroin disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests.
Documents
Issuer
LB PHARMACEUTICALS INC
CIK 0001691082
Entity typeother
Related Parties
1- filerCIK 0001397513
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 6:09 PM ET
- Size
- 15.1 KB